This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

The Aftermath: The Future of the Life Sciences Industries Beyond the Global Recession

Join Deloitte at BIO2010

Conference: Breakout Sessions
Track: Global Biotechnology Issues
Date: Wednesday May 5, 2010
Time: 4:00 PM - 5:30 PM
Location: McCormick Place, Chicago
Room: S403B


Life sciences executives are struggling to understand what the lasting effects of the global financial and economic crisis will be on the industry's business priorities and strategies. How has the restructuring of the industry been impacted by economic upheaval and are changes in direction over the last year or so temporary or permanent? Have companies’ strategies been permanently affected by the global economic recession and are they likely to behave differently as recovery occurs?

The session will:

  • Explore the impact of the current global economic crisis on the life sciences segments
  • Examine issues such as how the restructuring of the industry has been impacted by economic upheaval, whether changes in direction over the last year are temporary, and whether business strategies and priorities will be permanently affected by the current economic climate
  • Contrast panelists’ views with the results with the 300+ responses to a life sciences executive survey on these topics


  • Nigel Holloway, Moderator, Director of Research, The Economist
  • Pete Mooney, Global LSHC Consulting Leader, Deloitte Consulting LLP
  • Barbara Mittelman, MD, Director, NIH Program on Public-Private Partnerships, NIH
  • Dan Zabrowski, Global head of Pharmaceuticals Partnering, Roche

Last updated

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options

Stay connected